Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis

Fig. 5

mRNA expression levels for inflammatory markers were lower in HGC-TAC-treated MRL/lpr mice. ICAM-1 intercellular adhesion molecule-1, VCAM-1 vascular cell adhesion molecule-1, MCP-1 monocyte chemoattractant protein-1, IL-1 β interleukin 1β, IL-6 interleukin 6, TNF-α tumor necrosis factor-α, IMF-γ interferon-γ (n = 6 mice/group). The values for WT vehicle-treated group are set to 1. Data are shown as means ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001. ns not statistically significant

Back to article page